Insight

Oct 10, 2024, 15:57

New ESMO Open editorial on Immunotherapy in breast cancer

ESMO Open shared a recent article by Paola Zagami on X:

“Immunotherapy in the treatment landscape of hormone receptor-positive (HR+) early breast cancer: is new data clinical practice changing?”

Dario Trapani shared a post on X:

“Don’t miss the new ESMO Open editorial on Immunotherapy in breast cancer.”

Title: Immunotherapy in the treatment landscape of hormone receptor-positive (HR+) early breast cancer: is new data clinical practice changing?

Authors: P. Zagami, J. Cortés, L.A. Carey and G. Curigliano.

New ESMO Open editorial on Immunotherapy in breast cancer

Source: ESMO Open/X and Dario Trapani/X

Dario Trapani is a medical oncologist at the European Institute of Oncology (IEO) and a researcher in the Department of Oncology and Hemato-oncology at the University of Milan. He previously served as a Postdoctoral Researcher at the Dana-Farber Cancer Institute and is focused on population health research.

Breast Cancer cancer Dario Trapani ESMO Open European Institute of Oncology G Curigliano immunotherapy J. Cortes L.A. Carey OncoDaily Oncology P. Zagami University of Milan

Stanley Tucci and Throat Cancer: How He Went Against, How He Survived, and More

Senator John Fetterman Responds to Oncodaily on Pediatric Oncology Funding

Does Processed Meat Cause Cancer? Myths and Facts

Global Health Dialogues with Princess Dina Mired | Episode 1: Dr. Firas Al-Hawari

NEW PAPER ALERT: ESOPEC trial on Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer